Vimarsana
Biggest News Aggregation in the World

Page 4 - Alvr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alvr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alvr Today - Breaking & Trending Today

Bank of America Begins Coverage on AlloVir (NASDAQ:ALVR) - Vimarsana News

Bank of America Begins Coverage on AlloVir (NASDAQ:ALVR)

Bank of America assumed coverage on shares of AlloVir (NASDAQ:ALVR – Free Report) in a report published on Friday, MarketBeat.com reports. The brokerage issued a buy rating and a $17.00 target price on the stock. Other equities analysts have also issued reports about the company. SVB Securities upped their target price on AlloVir from $16.00 […]

AlloVir (NASDAQ:ALVR) Earns Buy Rating from Analysts at Bank of America - Vimarsana News

AlloVir (NASDAQ:ALVR) Earns Buy Rating from Analysts at Bank of America

Equities researchers at Bank of America began coverage on shares of AlloVir (NASDAQ:ALVR – Get Free Report) in a note issued to investors on Friday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. Several other brokerages have also weighed in on ALVR. Morgan Stanley restated an “overweight” rating and issued a $20.00 […]

Source: wkrb13.com
AlloVir Shares Rise on Bank of America's Bullish Call - Vimarsana News

AlloVir Shares Rise on Bank of America's Bullish Call

By Dean Seal Shares of AlloVir are climbing after Bank of America initiated coverage of the company with a buy rating, citing its innovative platform and the...

AlloVir (NASDAQ:ALVR) Given "Overweight" Rating at Morgan Stanley - Vimarsana News

AlloVir (NASDAQ:ALVR) Given "Overweight" Rating at Morgan Stanley

Morgan Stanley restated their overweight rating on shares of AlloVir (NASDAQ:ALVR – Free Report) in a report released on Monday, Benzinga reports. Morgan Stanley currently has a $20.00 price target on the stock. Separately, SVB Securities raised their price target on shares of AlloVir from $16.00 to $19.00 in a research report on Wednesday, April […]

AlloVir (ALVR) Scheduled to Post Quarterly Earnings on Wednesday - Vimarsana News

AlloVir (ALVR) Scheduled to Post Quarterly Earnings on Wednesday

AlloVir (NASDAQ:ALVR – Get Free Report) is set to post its quarterly earnings results on Wednesday, August 2nd. AlloVir (NASDAQ:ALVR – Get Free Report) last released its quarterly earnings results on Thursday, May 4th. The company reported ($0.44) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.03. On average, analysts expect AlloVir […]